HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Diazepam (Valium)

A benzodiazepine with anticonvulsant, anxiolytic, sedative, muscle relaxant, and amnesic properties and a long duration of action. Its actions are mediated by enhancement of GAMMA-AMINOBUTYRIC ACID activity.
Also Known As:
Valium; Seduxen; 7-Chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one; Apaurin; Diazemuls; Faustan; Relanium; Sibazon; Stesolid; 2H-1,4-Benzodiazepin-2-one, 7-chloro-1,3-dihydro-1-methyl-5-phenyl-
Networked: 4432 relevant articles (405 outcomes, 505 trials/studies)

Relationship Network

Drug Context: Research Results

Experts

1. Carrazana, Enrique: 12 articles (01/2022 - 01/2020)
2. Rabinowicz, Adrian L: 12 articles (01/2022 - 10/2014)
3. Huang, Tiao-Lai: 11 articles (10/2018 - 02/2005)
4. Parle, Milind: 11 articles (03/2012 - 10/2003)
5. Cook, James M: 8 articles (01/2022 - 06/2009)
6. Sperling, Michael R: 8 articles (01/2022 - 10/2014)
7. Wheless, James W: 8 articles (01/2022 - 12/2005)
8. Löscher, Wolfgang: 7 articles (10/2016 - 10/2002)
9. Desai, Jay: 6 articles (01/2022 - 01/2021)
10. Tarquinio, Daniel: 6 articles (01/2022 - 01/2020)

Related Diseases

1. Seizures (Absence Seizure)
2. Status Epilepticus (Complex Partial Status Epilepticus)
3. Febrile Seizures (Febrile Seizure)
01/01/2021 - "There was a significant reduction of recurrent febrile seizures with intermittent diazepam versus placebo or no treatment at six months (risk ratio (RR) 0.64, 95% confidence interval (CI) 0.48 to 0.85; 6 studies, 1151 participants; moderate-certainty evidence), 12 months (RR 0.69, 95% CI 0.56 to 0.84; 8 studies, 1416 participants; moderate-certainty evidence), 18 months (RR 0.37, 95% CI 0.23 to 0.60; 1 study, 289 participants; low-certainty evidence), 24 months (RR 0.73, 95% CI 0.56 to 0.95; 4 studies, 739 participants; high-certainty evidence), 36 months (RR 0.58, 95% CI 0.40 to 0.85; 1 study, 139 participants; low-certainty evidence), 48 months (RR 0.36, 95% CI 0.15 to 0.89; 1 study, 110 participants; moderate-certainty evidence), with no benefit at 60 to 72 months (RR 0.08, 95% CI 0.00 to 1.31; 1 study, 60 participants; very low-certainty evidence). "
01/01/2017 - " was a significant reduction of recurrent febrile seizures with intermittent diazepam versus placebo or no treatment, with a risk ratio (RR) of  0.64 (95% confidence interval (CI) 0.48 to 0.85 at six months), RR of 0.69 (95% CI 0.56 to 0.84) at 12 months, RR 0.37 (95% CI 0.23 to 0.60) at 18 months, RR 0.73 (95% CI 0.56 to 0.95) at 24 months, RR 0.58 (95% CI 0.40 to 0.85) at 36 months, RR 0.36 (95% CI 0.15 to 0.89) at 48 months, with no benefit at 60 to 72 months. "
07/01/2013 - "There was a significant reduction of recurrent febrile seizures with intermittent oral diazepam versus placebo with a relative risk (RR) of 0.67 (95% confidence interval (CI) 0.48 to 0.94) at 24 months), RR of 0.61 (95% CI 0.15 to 0.89) at 48 months, with no benefit at 6, 12 or 72 months. "
04/18/2012 - " was a significant reduction of recurrent febrile seizures with intermittent oral diazepam versus placebo with a relative risk (RR) of  0.67 (95% confidence interval (CI) 0.48 to 0.94) at 24 months), RR of 0.61 (95% CI 0.15 to 0.89) at 48 months, with no benefit at 6, 12 or 72 months. "
09/01/2000 - "However, diazepam used in the hospital was found to be effective in controlling acute febrile seizures."
4. Pain (Aches)
5. Poisoning

Related Drugs and Biologics

1. Midazolam (Versed)
2. Phenobarbital (Luminal)
3. Benzodiazepines
4. Anticonvulsants (Antiepileptic Drugs)
5. Phenytoin (Dilantin)
6. Lorazepam (Ativan)
7. Valproic Acid (Depakote)
8. Pentylenetetrazole (Metrazol)
9. Atropine
10. Carbamazepine (Tegretol)

Related Therapies and Procedures

1. Therapeutics
2. Rectal Administration
3. Premedication
4. Psychology Biofeedback (Biofeedback)
5. Aftercare (After-Treatment)